A comparative analysis of gene-expression data of multiple cancer types
- PMID: 21060876
- PMCID: PMC2965162
- DOI: 10.1371/journal.pone.0013696
A comparative analysis of gene-expression data of multiple cancer types
Abstract
A comparative study of public gene-expression data of seven types of cancers (breast, colon, kidney, lung, pancreatic, prostate and stomach cancers) was conducted with the aim of deriving marker genes, along with associated pathways, that are either common to multiple types of cancers or specific to individual cancers. The analysis results indicate that (a) each of the seven cancer types can be distinguished from its corresponding control tissue based on the expression patterns of a small number of genes, e.g., 2, 3 or 4; (b) the expression patterns of some genes can distinguish multiple cancer types from their corresponding control tissues, potentially serving as general markers for all or some groups of cancers; (c) the proteins encoded by some of these genes are predicted to be blood secretory, thus providing potential cancer markers in blood; (d) the numbers of differentially expressed genes across different cancer types in comparison with their control tissues correlate well with the five-year survival rates associated with the individual cancers; and (e) some metabolic and signaling pathways are abnormally activated or deactivated across all cancer types, while other pathways are more specific to certain cancers or groups of cancers. The novel findings of this study offer considerable insight into these seven cancer types and have the potential to provide exciting new directions for diagnostic and therapeutic development.
Conflict of interest statement
Figures
Similar articles
-
A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.PLoS Med. 2006 Dec;3(12):e486. doi: 10.1371/journal.pmed.0030486. PLoS Med. 2006. PMID: 17194187 Free PMC article.
-
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.Cancer Res. 2003 Dec 15;63(24):8614-22. Cancer Res. 2003. PMID: 14695172
-
Genes overexpressed in different human solid cancers exhibit different tissue-specific expression profiles.Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13122-7. doi: 10.1073/pnas.0705824104. Epub 2007 Jul 30. Proc Natl Acad Sci U S A. 2007. PMID: 17664417 Free PMC article.
-
National Oncology Forum: perspectives for the year 2000.Cancer J. 2001 Jul-Aug;7 Suppl 1:S2-13. Cancer J. 2001. PMID: 11504281 Review.
-
The analysis of microRNA-34 family expression in human cancer studies comparing cancer tissues with corresponding pericarcinous tissues.Gene. 2015 Jan 1;554(1):1-8. doi: 10.1016/j.gene.2014.10.032. Epub 2014 Oct 22. Gene. 2015. PMID: 25452192 Review.
Cited by
-
Sex-biased differences in the correlation between epithelial-to-mesenchymal transition-associated genes in cancer cell lines.Oncol Lett. 2019 Dec;18(6):6852-6868. doi: 10.3892/ol.2019.11016. Epub 2019 Oct 29. Oncol Lett. 2019. PMID: 31807189 Free PMC article.
-
A comparative study of gene-expression data of basal cell carcinoma and melanoma reveals new insights about the two cancers.PLoS One. 2012;7(1):e30750. doi: 10.1371/journal.pone.0030750. Epub 2012 Jan 25. PLoS One. 2012. PMID: 22295108 Free PMC article.
-
HEPATOKIN1 is a biochemistry-based model of liver metabolism for applications in medicine and pharmacology.Nat Commun. 2018 Jun 19;9(1):2386. doi: 10.1038/s41467-018-04720-9. Nat Commun. 2018. PMID: 29921957 Free PMC article.
-
Hierarchical gene selection and genetic fuzzy system for cancer microarray data classification.PLoS One. 2015 Mar 30;10(3):e0120364. doi: 10.1371/journal.pone.0120364. eCollection 2015. PLoS One. 2015. PMID: 25823003 Free PMC article.
-
Open Data for Differential Network Analysis in Glioma.Int J Mol Sci. 2020 Jan 15;21(2):547. doi: 10.3390/ijms21020547. Int J Mol Sci. 2020. PMID: 31952211 Free PMC article.
References
-
- WHO. Data and statistics. World Health Organization; 2006.
-
- Ries LAG MD, Krapcho M. SEER Cancer Statistics Review, 1975–2005. National Cancer Institute; 2008.
-
- Catalona WJ, Smith DS, Wolfert RL, Wang TJ, Rittenhouse HG, et al. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening. JAMA. 1995;274:1214–1220. - PubMed
-
- Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, et al. Delineation of prognostic biomarkers in prostate cancer. Nature. 2001;412:822–826. - PubMed
-
- Matei D, Graeber TG, Baldwin RL, Karlan BY, Rao J, et al. Gene expression in epithelial ovarian carcinoma. Oncogene. 2002;21:6289–6298. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources